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Post-pancreatectomy hemorrhage
Epidemiology, classification and etiology
Pancreatoduodenectomy (PD) is known to be one of the 
most complex abdominal surgeries. Morbidity has decreased 
in the last years but is still reported between 30% and 40% 
(1,2), while peri-operative mortality at high volume centers 
is <3% (3,4). Post-pancreatectomy hemorrhage (PPH) is a 
relatively rare event, being reported in up to 10% of cases, 
but is responsible for 10–38% of mortality (5-14). The 
severity of this complication is confirmed by recent studies: 
patients with PPH showed more than a 6-fold increase in 
mortality when compared to those not affected, with 64% 
and 35% of them requiring one or multiple interventions, 
respectively (6).
The International Study Group for Pancreatic Surgery 
(ISGPS) created a classification based on bleeding onset 
(early if <24 h after surgery, delayed when >24 h), location 
(intraluminal or extraluminal), and severity (grade A, B, or 
C). PPH is classified as grade A when occurring early and 
having no major clinical impact; grade B includes early 
severe and delayed mild cases that require transfusions, 
intermediate care unit observation, or intervention; 
grade C PPH is a delayed, severe hemorrhage requiring 
intervention and should always be considered potentially 
life-threatening (15).
The distinction between early and delayed post-
pancreatectomy hemorrhage (DPH) is crucial because 
they have different frequencies, etiologies and treatment 
strategies. DPH represent the majority of cases of PPH 
(14,16), with an incidence of 3.9% after pancreatic resection 
and a high mortality (between 30% and 50%) as reported 
by a metanalysis and a large series (17,18). The majority 
of DPH are arterial in origin (2,18); in a meta-analysis, 
pseudoaneurysms (PSA) were found to be involved in 
approximately one-third of cases (17). Regarding etiology, 
early hemorrhage is frequently a result of technical 
failure or vasospasm of small vessels on the surface of the 
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pancreatic resection (16,19), while DPH has been widely 
associated to vessel erosion caused by anastomotic leakage 
including pancreatic fistula, infection, or intra-abdominal 
abscess (16-18,20-23). Among these causes, pancreatic 
fistula is the far most common. A meta-analysis reported 
intra-abdominal abscesses and/or anastomotic leaks in 65% 
of DPH patients (17) and recent studies have confirmed this 
strong association with a fistula being found in up to 80% 
of DPH cases (2,14,24). Clinically significant postoperative 
pancreatic fistula not only was the most uniformly 
associated and independent risk factor for the development 
of DPH (7,13,22,25,26), but also increased of 17-fold the 
bleeding-related mortality (12).
Clinical manifestation, diagnosis and management
While early PPH occurs by definition within 24 h from 
resection, DPH can occur many days and even weeks 
later, with a median onset reported of 10–27 days after 
surgery (10,17,27), a range as wide as 4–240 days post-
operation (28), and a large part of events occurring after 
discharge from hospital (2,11). Intraluminal PPH is defined 
as the occurrence of blood draining from the nasogastric 
tube, hematemesis, or melena, and is frequently associated 
with ulcers at the anastomotic site or anastomotic fistulae 
possibly causing rupture of a PSA. Extraluminal PPH is 
defined as the occurrence of blood in drains or in an intra-
abdominal location, and is frequently caused by pancreatic 
fistulae (17,29). However, if anastomotic dehiscence is 
present, extraluminal blood can present as intraluminal and 
vice versa (18,30). The most common initial presentation of 
delayed PPH has been reported to be intraluminal in nature 
by some authors (2,11) and extraluminal by others (17,18). 
A particular clinical presentation pattern of post-operative 
bleeding is known as Quincke’s triad, which is defined as the 
presence jaundice, biliary colic and signs of gastrointestinal 
hemorrhage; this entity occurs when a PSA of the hepatic 
artery ruptures into the biliary tree (31). Since up to 76% of 
the PSA involving the hepatic artery ultimately undergoes 
rupture and the mortality rate of such event ranges from 
35% to 50%, an aggressive management is mandatory (32). 
The initial sign of PPH can also be sentinel bleeding, 
defined as a self-limiting episode of bleeding in the form 
of blood loss from a drainage, hematemesis, melena, 
and/or a minor drop in hemoglobin count, with the 
patient remaining stable. This particular manifestation, 
corresponding to grade B delayed and mild PPH when 
applying the ISGPS classification system, is of outmost 
importance, since it implies a structural vascular defect 
and may precede the development of hemorrhagic shock 
(25,33,34). In fact, sentinel bleeding precedes a severe 
PPH in 50–80% of patients and thus requires immediate 
diagnostic workup (1,9,10,18,21,22,26,35). Some authors 
have suggested to perform an angiographic study for every 
sentinel bleeding after pancreatic surgery (34), but the 
source cannot be demonstrated in many cases, probably due 
to the intermittent character of hemorrhage (30).
When PPH occurs, decisions regarding the most 
diagnostic or therapeutic intervention are made on the 
basis of two main aspects: patient’s hemodynamic status 
and CT findings (22). In case of hemodynamic instability, 
regardless of the timing of bleeding, urgent laparotomy 
is usually indicated. Many authors routinely advocate 
immediate reoperation in every case of early PPH, avoiding 
poly-transfusions and any delay in treatment (22,36). In 
fact, early PPH is most commonly the result of incomplete 
hemostasis and thus can be effectively managed by surgical 
reintervention (18). When the patient is hemodynamically 
stable, it’s generally recommended to perform abdominal 
and pelvic multidetector computer tomography (MDCT) 
angiography as soon as sentinel bleeding is observed, when 
sensitivity is highest (12,22,29,37,38). MDCT angiography 
can show the cause, nature and site of bleeding, being 
a fundamental tool as it can avoid or guide treatment 
(10,15,39-41). Nonetheless, even if MDCT is performed, 
a clear bleeding site cannot be identified in many cases (1). 
This is especially true when imaging is delayed, unless a 
clear structural vascular abnormality or a PSA are the cause 
of bleeding (29). Although several studies are in favour 
of upper endoscopy when intraluminal hemorrhage is 
suspected (19), recent reports have shown that not only it 
may result inconclusive in the identification of the source 
of bleeding, but most importantly positive findings at 
endoscopic examination (for example erosive gastritis) 
may be dangerous as they can delay intervention, possibly 
causing death (16,17,42,43). Moreover, MDCT was recently 
proved to be superior to endoscopy in the diagnosis of upper 
intraluminal bleeding (44). When, after an initial diagnostic 
workup, the source of bleeding remains uncertain, it’s 
generally recommended to perform diagnostic angiography 
of the celiac axis and superior mesenteric artery. This 
procedure can demonstrate direct signs of bleeding, as 
active contrast extravasation, or indirect signs, like spastic 
and irregular vessels (29). Diagnostic angiography can be 
limited, however, in cases of diffuse, venous, or intermittent 
hemorrhage.
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DPH represents to date a major cause of postoperative 
mortality; this complication is extremely difficult to manage 
because of the unstable clinical condition of the patients, 
that deteriorates rapidly (18,22). In the past, laparotomy has 
been considered as the treatment of choice for DPH (45). 
Surgical reintervention can achieve hemostasis but also has 
the advantage of allowing treatment of the factors associated 
with DPH, like fistulae or abdominal collections (17). 
Nonetheless, urgent re-look laparotomy is historically 
associated with high rates of morbidity and mortality, and 
surgery at this time is made challenging by postoperative 
adhesions and inflammation (10,46-48). The above-
mentioned difficulties are often encountered when a 
pancreatic leak is present, and in such cases a first-line 
non-operative approach is given high priority by many 
authors (2,11,18,36). Moreover, patients with DPH are 
most frequently critically ill, so it has to be considered 
that general anesthesia and a long surgical procedure may 
worsen their clinical condition and increase their risk of 
death (30). These issues have pushed advances and research 
in less invasive techniques like the ones of interventional 
radiology (IR).
Arteriography with embolization is a well-known 
technique (20,43,49). IR is less invasive than surgery, 
doesn’t always need to be followed by Intensive Unit care, 
and allows a faster recovery and discharge (22). In the last 
years a number of studies have been reported about the 
management of DPH by IR, which has proven to be safe 
and effective, gaining more and more acceptance, and 
a clear shift toward its use has been widely documented 
(2,7,17-19,23,36,43,50,51). Today, endovascular treatment 
with percutaneous approach is recommended as the first 
choice by many authors in patients with DPH; exceptions 
are represented by cases in which adequate resuscitation 
cannot be achieved or in cases of logistic issues (7,10,14, 
15,17,22,29,33,37,52,53). The importance of the patient’s 
hemodynamic status was confirmed by a systematic review in 
which instability resulted the main cause for not performing 
angiography (10). Some authors advocate to always attempt 
the restoration of hemodynamic stability, even in critical 
cases, in order to allow endovascular intervention and avoid 
surgery; when surgical intervention is indeed performed 
on unstable and non-resuscitable patients, a deleterious 
outcome is frequently expected. The same authors conclude 
that IR is the best treatment for major visceral arterial 
bleeding when performed by experienced radiologists, and 
thus should be preferred over surgery whenever feasible (37). 
Nonetheless, there is no universally accepted treatment 
algorithm for patients with DPH, a well-recognized but 
also relatively uncommon, complication. It’s difficult to 
formulate firm recommendations, too (1,2,6,7,17). Several 
authors have tried to propose treatment algorithms but 
most of their studies are limited by small populations and 
low complication rates; the studies with larger populations, 
on the other hand, are characterized by prolonged eras 
(2,14,17,18,30). Some grade of inability in predicting the 
most suitable treatment for each patient still remains, with 
some authors concluding that the type of intervention 
requested in patients with DPH is unpredictable, sometimes 
even within a single institution (7,10,17,53). In a recent 
study a univariate analysis was performed to detect any 
predictors of which type of emergency intervention, surgical 
or radiological, the patient with DPH should initially 
receive, but no significant predictors were found (7). 
Efficacy and roles of IR and surgery
Surgical treatment of post-pancreatectomy bleeding is 
associated with high rates of morbidity and mortality (46). 
A number of studies (Table 1) have analyzed the role of 
IR in patients with DPH, especially in cases where a PSA 
or major arterial bleeding were involved, and reported 
high success rates (36,37,54,55,62,63). In literature, 
technical success of endovascular treatment of DPH is 
reported between 82% and 100%; in the same studies 
recurrent bleeding is reported between 7% and 30%, 
hepatic complications between 12% and 63%, mortality 
between 7% and 54% (9,20,27,33,43,52,53). Several 
studies, including one systematic review, have reported a 
significantly lower mortality of IR when compared with 
surgical care (10,27,29,43). In the specific setting of visceral 
artery PSAs, which represent at least one third of causes of 
DPH (17), angiography was found to be associated with a 
fourth of the mortality of surgery, shorter operating time, 
lower blood loss, and shorter intensive care time, with an 
overall success rate at achieving hemostasis of 87% (56). A 
metanalysis analyzing 163 cases of DPH after PD found no 
statistically significant differences between IR and surgery 
in the rates of complete hemostasis achieved, complications 
or mortality; nonetheless, trends in favour of IR were 
observed in terms of complication rates (70% in surgical 
group vs. 36% in endovascular group) and mortality (43% 
vs. 21%) (17). A more recent systematic review did report 
a statistically significant difference in terms of mortality 
(22% for IR vs. 47% for laparotomy), a result that strongly 
supports the use of IR (10). 
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To our knowledge, no prospective randomized clinical 
trial comparing surgery and IR in the setting of DPH has 
been conducted to date, mostly because of the limited 
numbers of events; as a consequence, there is no evidence 
suggesting the superiority of one strategy over the other. 
The management is still ultimately decided on the basis 
of the characteristics and clinical status of the individual 
patient, together with the institutional preference and 
expertise. However, IR is widely considered as the potential 
first-line treatment in patients that are hemodynamically 
stable, while an aggressive surgical intervention is the 
preferred option in patients that are unstable or when others 
treatments have failed (17,28). Surgery continues to have an 
important role in the treatment of the causes of hemorrhage 
(as abdominal collections or fistulae) in patients where 
acute bleeding has been successfully managed by IR (37). 
Table 1 Outcome of endovascular treatment of hemorrhage after pancreatic surgery
Study
Patients  
(n)
Timing of  
hemorrhage
Type of 
procedure
Technical 
success (%)
Recurrent 
bleeding (%)
Hepatic 
complications (%)
Mortality  
(%)
Gaudon et al., 2016 (1) 42 DPH E + S 69 28 12 13
Asai et al., 2015 (2) 32 DPH E + S – 22 6.2 13
Jilesen et al., 2014 (7) 14 DPH E + S 71 7 – 7
Lee et al., 2010 (9) 23 DPH (PSA) E 91 13 26 13
Asari et al., 2016 (14) 19 EPH + DPH E 79 – – 20
Yekebas et al., 2007 (18) 43 EPH + DPH E 58 – – 27
Choi et al., 2004 (20) 10 DPH E 100 20 20 20
Mañas-Gómez et al., 2011 (22) 8 EPH + DPH E 75 25 – –
Yoon et al., 2003 (23) 8 EPH + DPH E 88 - – –
Ching et al., 2016 (24) 28 DPH E + S 97 26 0 7
Ansari et al., 2017 (25) 10 EPH + DPH E + S 80 – – –
Hur et al., 2011 (27) 16 DPH (PSA) E 100 19 19 12
Hassold et al., 2016 (28) 27 DPH E + S 100 7 22 23
Zhang et al., 2011 (30) 11 DPH E 90 – – 18
Beyer et al., 2009 (35) 9 DPH E + S 100 22 – –
Schäfer et al., 2011 (37) 12 DPH E + S 83 25 – 25
Gwon et al., 2011 (52) 27 EPH + DPH E + S 100 7 33 7
Khalsa et al., 2015 (54) 6 DPH E + S 100 33 – 17
Darnis et al., 2013 (55) 14 DPH E 50 – – –
Ding et al., 2011 (56) 23 DPH (PSA) E + S 87 4 4 9
Stoupis et al., 2007 (57) 5 DPH S 100 0 0 60
Pedersoli et al., 2016 (58) 10 DPH (PSA) S 90 10 0 0
Bellemann et al., 2014 (59) 24 DPH
†
S 88 8 12 21
Lim et al., 2014 (60) 17 DPH
†
S 94 12 17 12
Stampfl et al., 2012 (61) 25 DPH E 83 15 – 20
†
, in this paper the majority of cases were delayed hemorrhages after surgery but a minority were patients bleeding from the hepatic artery 
after other types of abdominal surgery. DPH, delayed post-pancreatectomy hemorrhage; E, embolization; EPH, early post-pancreatectomy 
hemorrhage; PSA, pseudoaneurysm; S, stenting.
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It has to be pointed out that bleeding control must be 
followed by treatment of the underlying cause, most 
commonly represented by pancreatic fistula, either with 
IR or surgery, to ensure the best clinical outcomes for the 
patients. To avoid transportation it is desirable for the 
interventional and surgical team to have the possibility of 
working in close proximity to the place where the medical 
team is resuscitating. This can be achieved with the use of a 
hybrid operating room (64,65). 
IR
Techniques and scenarios
Transcatheter arterial embolization is a well established, 
safe and effective treatment for ruptured PSA (59,61,66-68) 
as hemostasis is reached in 80% to 100% of patients (1). 
According to different papers, the gastroduodenal artery 
(GDA) stump is the most common bleeding site, followed 
by common hepatic artery (CHA), left hepatic artery, dorsal 
pancreatic artery, gastric artery, splenic artery (Figure 1), and 
the superior mesenteric artery, in different orders according 
to some different experiences(1,14,27,28,52,69). The 
majority of DPH are, according to the ISGPS classification, 
extraluminal (30). A range of different techniques are 
available to stop the hemorrhage once the bleeding source 
has been identified. When the target vessel is terminal 
in location, its proximal embolization is usually enough 
to stop the bleeding; on the other hand, if collaterals are 
Figure 1 A patient presented with significative anemization 3 days after pancreatic surgery. (A) An urgent CT scan was performed that 
revealed a pseudoaneurysm of the splenic artery; (B) the finding was confirmed at arteriography; (C,D) embolization was performed 
deploying coils distally and proximally to the PSA (“sandwich” technique), and completed with 1 cc of cyanoacrylate; (E,F) a control MDCT 
scan confirmed the exclusion of the pseudoaneurysm and the absence of bleeding. PSA, pseudoaneurysm; MDCT, multidetector computer 
tomography.
A B C
D E F
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present, both the inflow and outflow vessels have to be 
embolized (the so-called “sandwich” technique) in order 
to avoid re-bleeding (Figure 1) (70). Vascular occlusion 
can be obtained exploiting a wind range of materials, with 
the choice made primarily according to the desired type 
of vascular occlusion (transient or permanent). Transient 
embolization is reached using resorbable materials (i.e., 
gelatine or fibrin sponge), which allows for reperfusion of 
the treated area after a variable window of time. The main 
advantage is to avoid the definitive occlusion of the treated 
vessel. However, a non-negligible risk of rebleeding must 
be taken into account once the material has been absorbed. 
Permanent embolisation is reached using non-resorbable 
materials that induce a permanent vessel occlusion. To 
date, there is no consensus regarding an ideal embolizing 
agent; nevertheless, every case may need a specific embolic 
agent and the prompt availability of the material is required 
into any angio suite (41). The list of embolic materials 
includes polyvinyl alcohol, bucrilate, metallic coils or 
detachable balloons. Coils are suited when there is a single 
feeding vessel that can be sacrificed (Figure 2). Glue can be 
used to embolize small collaterals that cannot be directly 
catheterized. Balloon occlusion can be used as a temporary 
measure for protection of distal circulation.
Embolization of GDA stump or CHA
Since the GDA stump and the CHA are the two most 
common bleeding sites, this review will focus more 
specifically in the treatment options of these vessels. 
Two techniques of embolization have been described: 
embolization of the hepatic artery proximal and distal to 
the GDA stump, or selective embolization of the GDA 
stump. Embolization of the hepatic artery is technically 
Figure 2 During pancreatic surgery a mesenteric vessel was unintentionally damaged. Hemorrhage was treated surgically with packing and 
compression but significative anemization was still observed. (A,B) A MDCT scan was performed which revealed a superior mesenteric 
artery (SMA) pseudoaneurysm with signs of active bleeding; (C,D) arteriography confirmed the active blushing at the level of the SMA; (E,F) 
selective embolization was successfully performed using 2–3 mm coils. MDCT, multidetector computer tomography.
A B C
D E F
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easy and usually allows a definite control of the bleeding, 
but it can lead to severe hepatic ischemic complications (71); 
infarction has been described in 30% to 66% of cases after 
using this technique in various studies (23,53) and therefore 
verification of portal vein (PV) patency is always mandatory 
before hepatic artery embolization (53,72). Selective 
embolization of the GDA stump allows to preserve hepatic 
arterial flow but is technically more complex and sometimes 
non-feasible, depending on the length of the stump and the 
morphology of the PSA, and is more prone to rebleeding, 
too (27,50,67,73). Hur et al. reported 100% rate of bleeding 
recurrence when selective embolization of the GDA stump 
was performed trying to spare the hepatic arterial flow; 
rebleeding was demonstrated to possibly occur not only at 
the GDA stump again, but also along any other portion of 
the extrahepatic segments of the hepatic arteries, especially 
when exposed to free pancreatic fluid. Whenever the 
bleeding is suspected to be associated with a pancreatic 
fistula, they therefore suggest to perform an aggressive 
embolization, comprehensive of the proper and common 
hepatic arteries (27). A PSA that is not yet excluded after 
embolization can be managed with percutaneous injection 
of thrombin under ultrasound or CT guidance (74). 
Stent-grafts
In the last years, thanks to the advancements in technology 
and the wide commercial availability, an increasing 
number of papers have described the use of stent-grafts for 
endovascular repair of visceral aneurysms and PSAs (74). In 
the particular setting of a PPH, placing a stent-graft instead 
of using permanent embolic agents allows to maintain the 
hepato-portal blood flow and to reduce complications such 
as postembolization syndrome, liver abscess formation, 
and liver failure (28). For these reasons some authors have 
suggested that releasing a stent-graft into the hepatic 
artery, excluding the GDA stump, should be considered as 
a first-line procedure (9,75). According to some reports, 
covered stent-grafts are associated with a diminished risk 
of recurrent hemorrhage when compared to selective 
embolization (57,76). On the other hand, this technically 
challenging, especially in cases of difficult anatomy 
(9,27,52,72). The vascular access is generally performed via 
a transfemoral approach, but in case of marked angulation 
of the celiac axis or median arcuate ligament syndrome, 
which is associated with higher rates of technical failure 
and complications, some authors have suggested a brachial 
or transhepatic access (29,77,78). In an emergency setting, 
when time becomes crucial, stent-graft placement can 
lead to immediate exclusion of the target PSA with a 
relatively short operative time (28). Moreover, stent graft 
implantation has been associated with a lower use of 
fluoroscopy during the procedure (58). The most common 
complications of stent graft implantations are endoleaks 
and stent thromboses (58,79), but stent dislocation and 
consequent rebleedings have also been described (80). 
Another potential severe complication is infection of the 
stent when contact with gastrointestinal content or infected 
necrotic tissue occurs (58). 
Currently, data over midterm and long-term stent patency 
are limited. Lim et al., in a mean follow-up of 356 days, 
reported a patency rate of 69% (60). Moreover, to date, 
there are no definite guidelines concerning the most 
appropriate anticoagulant therapy after implantation of 
arterial covered stents, and clinical experience is limited; 
nevertheless, after stent-graft implantation, an antiplatelet 
therapy is recommended. The general consensus is that 
clinically stable patients should receive acetylsalicylic acid 
100 mg daily on a lifelong basis (28). The choice of the 
correct stent, both in diameter and length, can be difficult. 
First, it is important to avoid undersizing, taking into 
account that the diameter of the affected vessel, especially 
in an emergency setting, is often decreased as a result of 
hypovolemia and vascular spasms; undersizing can lead to 
inappropriate sealing, endoleaks and stent migration (28,59). 
On the other hand, stent oversizing can lead to vessel 
rupture, and is a probable cause of stent thrombosis (52). 
To date, limited data are available on the topic of stent 
sizing, although generally the angiographic findings and 
the preinterventional MDCT scans are key elements in the 
interventional radiologist’s choice (28). Proper stent length 
with correct landing zones is essential to avoid rebleeding, 
especially in patients with vessel erosion due to pancreatic 
or anastomotic leakage. Contraindication to stent-graft 
implantation can be short- or wide-neck aneurysm, and 
tortuous, stenotic or small vessels (28,81,82).
Complications
Percutaneous arterial embolization is a procedure at risk of 
recurrent hemorrhage with not negligible mortality rate (1). 
In a recent study rebleeding was seen in 25% of patients and 
it was due to recurrent PSAs, rebleeding from coiled vessels, 
blocked stents and endoleaks. Recurrence of bleeding is 
usually related to persistence of the favoring factors (i.e., 
pancreatic/bile leak, persistent abscess) (24). The GDA 
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stump is the first spot to look for complications and surgical 
clips adjacent to the hepatic artery can aid in finding its 
position (29). Moreover, the patient’s outcome after the 
procedure can be worsened by hepatic complications such 
as the occurrence of postembolization liver failure or liver 
abscess (1). Septic shock, hemorrhagic shock, hepatic 
failure, and multiple organ failure are among the causes of 
death after IR in a meta-analysis, which occurred in 20% of 
treated patients (17). 
In general, the liver can tolerate considerable amounts of 
embolic agents because of its multiple collateral pathways, 
mainly via subphrenic arteries and PV. As long as these 
vessels are proved to be normally present and patent, some 
authors suggest that embolization proximal to the proper 
hepatic artery should lead to a successful outcome (30). 
Nevertheless, the occlusion of the hepatic artery can lead 
to cholangitis, hepatic abscess, or fatal hepatic failure (17). 
Temporary elevation of blood liver enzymes, with 
normalization within a mean time of 12 days, has also been 
reported in case of embolization at the level of the GDA 
stump (52).
Other vascular complications
PV stenosis and portal hypertension
When PD is accompanied by intraoperative radiotherapy 
or venous reconstructions some studies report a 13–20% 
incidence of portomesenteric venous obstruction (83-86). 
Portal hypertension (PH) can cause ascites, abdominal 
bloating and pain, with a major impact on quality of life, 
but can also lead to life-threatening conditions, like variceal 
hemorrhage (87). The initial assessment in PV stenosis is 
initially performed by Doppler ultrasonography, followed 
by MDCT, or magnetic resonance angiography (88). 
Treatment options for PV stenosis vary from minimally 
invasive and palliative, like anticoagulation and paracentesis, 
to potentially curative but more aggressive and high-
risk, such as open thrombectomy or portosystemic shunt 
creation. In these cases surgical approach is rarely chosen 
for various reasons: high morbidity and mortality rates, poor 
general condition of patients suffering from chronic disease, 
severe postoperative adhesions and high risk of bleeding 
from dilated collateral venous channels (69,87). High 
technical and clinical success rates, minimal invasiveness 
and low complication rates, have made the percutaneous 
endovascular approach the preferred treatment modality 
in the setting of PV stenosis (69). The first procedural 
step consists generally in venography, usually performed 
with percutaneous transhepatic approach. Transjugular, 
transsplenic, and intraoperative mesenteric vein approaches 
are also an option, with technical success rates reported 
between 66% and 100% (89,90). Recanalization of PV 
after PD (in some cases combined with intraoperative 
radiotherapy) can be achieved by the positioning of a stent 
with percutaneous approach; this can lead to symptomatic 
relief at the cost of minor morbidity and mortality in the 
majority of patients. However, stent patency and patient 
survival depend primarily on the course of the underlying 
oncologic disease; moreover, the small sample experiences 
found in literature can’t significantly support this treatment 
yet, also considering that the first reports of percutaneous 
recanalization of portomesenteric venous obstruction after 
PD showed a not negligible (29–50%) rate of restenosis 
that often required repeated intervention (91). In general, 
the positive outcome of endovascular PV recanalization 
seems to be related to the presence of tapering appearance 
of the patent vein, postoperative radiation treatment, length 
of occluded segment, malignant PV invasion, and presence 
of thrombotic component. Procedural complications are 
rare. These include hemothorax from the hepatic puncture 
site, pleural effusion, and unsatisfactory positioning of the 
stent (92).
Varices
With portal hypertension, splanchnic venous blood drains to 
the systemic system through collaterals and can lead to the 
development of varices in the duodenum, jejunum, or in the 
stomach. Among them, jejunal ectopic varices are the most 
commonly reported after hepatobiliary-pancreatic surgery. 
Collateral varices seem to form via low-resistant natural 
vascular spaces such as pancreaticoduodenal or gastrocolic 
veins along the afferent jejunal loop rather than newly 
formed postoperative tissue around the hepatic hilum (92). 
As a result, jejunal bleeding may happen. This event is 
rare and in literature only case reports or small series have 
reported it (93-96), as shown in Table 2. The two main 
options available are the treatment of the jejunal varices 
themselves or the decompression of the portal system via 
a trans-jugular portosystemic shunt; the choice between 
them generally depends on the clinical status of the patient. 
Direct treatment of the varices include their embolization 
via an endovascular approach or direct puncture technique, 
PV angioplasty and stenting, or both (94,97-100). In a series 
of 11 patients gastrointestinal bleeding from PV occlusion 
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and jejunal varices occurred, on average, 27 months after 
surgery (92). Therefore, it is not always easy to correlate the 
two events and the diagnosis may be delayed until massive 
gastrointestinal bleeding from ectopic varix occurs (99). To 
our knowledge, the most delayed bleeding complication 
after PD occurred 2.5 years after surgery. A patient 
manifested signs of portal hypertension which caused him 
refractory melena. A gastroscopy revealed bleeding from 
the jejunal loop the varices couldn’t be treated via this 
approach. Eventually, partial splenic embolization with coils 
was carried out, achieving a ±50% area of splenic ischemia 
and successful hemostasis. 
Conclusions
Vascular injuries after pancreatic surgery lead to dramatic 
consequences with high mortality and morbidity. Early 
recognition and treatment are essential to optimize 
the damage control and minimize complications and 
adverse events. Lately, IR intervention is becoming the 
preferred method to approach this condition because 
of a less invasivity and reduced mortality and several 
studies, including one systematic review, have reported a 
significantly lower mortality of IR when compared with 
surgical care. Transcatheter arterial embolization, in 
particular, has been shown to be a safe and effective first-
line treatment for ruptured PSA occurring after PD. A 
range of different materials are nowadays available and the 
recent advancements in stent-graft technology have led to 
an increase use in this setting, with the potential to further 
reduce hepatic complications, such as postembolization 
syndrome, liver abscesses, and organ failure.
IR has been also gaining a more central role in the 
treatment of PV-related complications after pancreatic 
surgery such as PV stenosis, gastroesophageal and jejunal 
varices bleeding, with good success and relatively low 
adverse events. 
Nevertheless, IR in this very specific field still remain 
a high-risk intervention with a significant percentage of 
recurrent hemorrhage and a high mortality rate. Therefore, 
that requires highly trained operators that could work in 
high-volume centers (101) and can establish a close and 
proficient collaboration with pancreatobiliary surgeons, 
anesthesiologists, and clinicians such hepatologists, 
oncologists and radiotherapists with the goal to improve the 
patient’s outcome and survival.
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